SAN FRANCISCO, CA--(Marketwire - August 02, 2011) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a teleconference and webcast with management to discuss second quarter financial results and provide a general business update on Tuesday, August 9, 2011 at 4:30 p.m. Eastern Time. A press release for the second quarter ended on June 30, 2011 will be released after markets close on August 9, 2011.
Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals interested in listening to the live call via webcast may do so by visiting www.medivation.com. A replay of the webcast will be available on the Company’s website for 30 days.
About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partners Astellas and Pfizer, Medivation currently has investigational drugs in Phase 3 development to treat advanced prostate cancer and mild-to-moderate Alzheimer’s disease. For more information, please visit us at www.medivation.com.
